Literature DB >> 33947397

Coronary lesion complexity in patients with heterozygous familial hypercholesterolemia hospitalized for acute myocardial infarction: data from the RICO survey.

Hermann Yao1, Michel Farnier1, Laura Tribouillard1,2, Frédéric Chague1, Philippe Brunel3, Maud Maza1, Damien Brunet3, Luc Rochette2, Florence Bichat1, Yves Cottin1, Marianne Zeller4.   

Abstract

BACKGROUND: Although patients with familial heterozygous hypercholesterolemia (FH) have a high risk of early myocardial infarction (MI), the coronary artery disease (CAD) burden in FH patients with acute MI remains to be investigated.
METHODS: The data for all consecutive patients hospitalized in 2012-2019 for an acute MI and who underwent coronary angiography were collected from a multicenter database (RICO database). FH (n = 120) was diagnosed using Dutch Lipid Clinic Network criteria (score ≥ 6). We compared the angiographic features of MI patients with and without FH (score 0-2) (n = 234) after matching for age, sex, and diabetes (1:2).
RESULTS: Although LDL-cholesterol was high (208 [174-239] mg/dl), less than half of FH patients had chronic statin treatment. When compared with non-FH patients, FH increased the extent of CAD (as assessed by SYNTAX score; P = 0.005), and was associated with more frequent multivessel disease (P = 0.004), multiple complex lesions (P = 0.022) and significant stenosis location on left circumflex and right coronary arteries. Moreover, FH patients had more multiple lesions, with an increased rate of bifurcation lesions or calcifications (P = 0.021 and P = 0.036, respectively). In multivariate analysis, LDL-cholesterol levels (OR 1.948; 95% CI 1.090-3.480, P = 0.024) remained an independent estimator of anatomical complexity of coronary lesions, in addition to age (OR 1.035; 95% CI 1.014-1.057, P = 0.001).
CONCLUSIONS: FH patients with acute MI had more severe CAD, characterized by complex anatomical features that are mainly dependent on the LDL-cholesterol burden. Our findings reinforce the need for more aggressive preventive strategies in these high-risk patients, and for intensive lipid-lowering therapy as secondary prevention.

Entities:  

Keywords:  Complex coronary lesions; Familial hypercholesterolemia; LDL cholesterol; Myocardial infarction

Year:  2021        PMID: 33947397     DOI: 10.1186/s12944-021-01467-z

Source DB:  PubMed          Journal:  Lipids Health Dis        ISSN: 1476-511X            Impact factor:   3.876


  35 in total

1.  Non-coronary heart disease mortality and risk of fatal cancer in patients with treated heterozygous familial hypercholesterolaemia: a prospective registry study.

Authors:  H A W Neil; M M Hawkins; P N Durrington; D J Betteridge; N E Capps; S E Humphries
Journal:  Atherosclerosis       Date:  2004-12-08       Impact factor: 5.162

2.  Prevalence, risk factor burden, and severity of coronary artery disease in patients with heterozygous familial hypercholesterolemia hospitalized for an acute myocardial infarction: Data from the French RICO survey.

Authors:  Michel Farnier; Clémence Salignon-Vernay; Hermann Yao; Frédéric Chague; Philippe Brunel; Maud Maza; Damien Brunet; Florence Bichat; Jean-Claude Beer; Yves Cottin; Marianne Zeller
Journal:  J Clin Lipidol       Date:  2019-06-21       Impact factor: 4.766

3.  Familial hypercholesterolemia in the danish general population: prevalence, coronary artery disease, and cholesterol-lowering medication.

Authors:  Marianne Benn; Gerald F Watts; Anne Tybjaerg-Hansen; Børge G Nordestgaard
Journal:  J Clin Endocrinol Metab       Date:  2012-08-14       Impact factor: 5.958

4.  Child-Parent Familial Hypercholesterolemia Screening in Primary Care.

Authors:  David S Wald; Jonathan P Bestwick; Joan K Morris; Ken Whyte; Lucy Jenkins; Nicholas J Wald
Journal:  N Engl J Med       Date:  2016-10-27       Impact factor: 91.245

5.  Prognosis of Patients With Familial Hypercholesterolemia After Acute Coronary Syndromes.

Authors:  David Nanchen; Baris Gencer; Olivier Muller; Reto Auer; Soheila Aghlmandi; Dik Heg; Roland Klingenberg; Lorenz Räber; David Carballo; Sebastian Carballo; Christian M Matter; Thomas F Lüscher; Stephan Windecker; François Mach; Nicolas Rodondi
Journal:  Circulation       Date:  2016-07-26       Impact factor: 29.690

6.  Prognostic impact of familial hypercholesterolemia on long-term outcomes in patients undergoing percutaneous coronary intervention.

Authors:  Maximilian Tscharre; Robert Herman; Miklos Rohla; Edita Piackova; Kris G Vargas; Serdar Farhan; Matthias K Freynhofer; Thomas W Weiss; Kurt Huber
Journal:  J Clin Lipidol       Date:  2018-09-22       Impact factor: 4.766

7.  2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk.

Authors:  François Mach; Colin Baigent; Alberico L Catapano; Konstantinos C Koskinas; Manuela Casula; Lina Badimon; M John Chapman; Guy G De Backer; Victoria Delgado; Brian A Ference; Ian M Graham; Alison Halliday; Ulf Landmesser; Borislava Mihaylova; Terje R Pedersen; Gabriele Riccardi; Dimitrios J Richter; Marc S Sabatine; Marja-Riitta Taskinen; Lale Tokgozoglu; Olov Wiklund
Journal:  Eur Heart J       Date:  2020-01-01       Impact factor: 29.983

8.  Diagnostic Yield and Clinical Utility of Sequencing Familial Hypercholesterolemia Genes in Patients With Severe Hypercholesterolemia.

Authors:  Amit V Khera; Hong-Hee Won; Gina M Peloso; Kim S Lawson; Traci M Bartz; Xuan Deng; Elisabeth M van Leeuwen; Pradeep Natarajan; Connor A Emdin; Alexander G Bick; Alanna C Morrison; Jennifer A Brody; Namrata Gupta; Akihiro Nomura; Thorsten Kessler; Stefano Duga; Joshua C Bis; Cornelia M van Duijn; L Adrienne Cupples; Bruce Psaty; Daniel J Rader; John Danesh; Heribert Schunkert; Ruth McPherson; Martin Farrall; Hugh Watkins; Eric Lander; James G Wilson; Adolfo Correa; Eric Boerwinkle; Piera Angelica Merlini; Diego Ardissino; Danish Saleheen; Stacey Gabriel; Sekar Kathiresan
Journal:  J Am Coll Cardiol       Date:  2016-04-03       Impact factor: 24.094

9.  Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society.

Authors:  Børge G Nordestgaard; M John Chapman; Steve E Humphries; Henry N Ginsberg; Luis Masana; Olivier S Descamps; Olov Wiklund; Robert A Hegele; Frederick J Raal; Joep C Defesche; Albert Wiegman; Raul D Santos; Gerald F Watts; Klaus G Parhofer; G Kees Hovingh; Petri T Kovanen; Catherine Boileau; Maurizio Averna; Jan Borén; Eric Bruckert; Alberico L Catapano; Jan Albert Kuivenhoven; Päivi Pajukanta; Kausik Ray; Anton F H Stalenhoef; Erik Stroes; Marja-Riitta Taskinen; Anne Tybjærg-Hansen
Journal:  Eur Heart J       Date:  2013-08-15       Impact factor: 29.983

10.  Comparison of long-term outcomes of young patients after a coronary event associated with familial hypercholesterolemia.

Authors:  Xu Wang; Gaojun Cai; Yingying Wang; Ran Liu; Ziwei Xi; Gexuan Li; Wenhui Wen; Yue Wu; Chenggang Wang; Qingwei Ji; Xinguo Wang; Qian Zhang; Yujie Zeng; Luya Wang; Wei Liu; Yujie Zhou
Journal:  Lipids Health Dis       Date:  2019-06-01       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.